• Insights
    • Blog
    • Perspectives
    • Webinars
  • Offerings
    • Strategic innovation
    • Digital innovation
    • Product innovation
    • High-tech innovation
    • On-site consulting
    • Verhaert NL
  • Markets
    • Space & security
    • FMCG
    • Life sciences
    • Industry
  • Capabilities
    • AILab
    • DesignLab
    • DigitalLab
    • EmbeddedLab
    • FabLab
    • InnoLab
    • MechLab
    • OpenLab
    • OpticsLab
    • PhysicsLab
  • Technologies
    • Technology portfolio
    • IoT & sensors
    • AI & data science
    • Robotics & autonomy
    • Cooling, heating & fluidics
  • About
    • News
    • Our story
  • Careers
  • Contact
Verhaert Masters in InnovationVerhaert Masters in Innovation
Verhaert Masters in InnovationVerhaert Masters in Innovation
  • Insights
        • Blog
        • Perspectives
        • Podcast
        • Webinars
        • FEATURED
          Innovation Day 2025
  • Offerings
        • Strategic
          innovation
        • Digital
          innovation
        • Product
          innovation
        • High-tech
          innovation
        • On-site
          consulting
        • FEATURED
          Verhaert NL
  • Markets
        • Space & defense
        • FMCG
        • Life sciences
        • Industry
  • Capabilities
        • AILab
        • DesignLab
        • DigitalLab
        • EmbeddedLab
        • FabLab
        • InnoLab
        • MechLab
        • OpenLab
        • OpticsLab
        • PhysicsLab
  • Technologies
        • IoT & sensors
        • AI & data science
        • Robotics & autonomy
        • Cooling, heating & fluidics
        • Optics
  • About
        • News
        • Our story
  • Careers
  • Contact

About Aimée Mugisha

This author hasn't written their bio yet.
Aimée Mugisha has contributed 2 entries to our website, so far.

The impact of decentralization on IVD engineering

The impact of decentralization on IVD engineering

May 7, 2026

In-vitro diagnostics (IVD) is moving past the era of ‘better specs’ and into the era of ‘systemic integration’. While decentralization...

The economics of scale: Solving the cell therapy manufacturing bottleneck

The economics of scale: Solving the cell therapy manufacturing bottleneck

Mar 3, 2026

See how automated, user-centric systems are enabling cell therapies to move from bespoke lab success to industrial market victory.

NEWSLETTER
OTHER CONTENT
  • How to accelerate innovation in new product development
  • Industry – Rebuilding industrial capacity and the innovation challenges it brings
  • Space & Defense – From a closed industry toward an open innovation ecosystem
Verhaert group

Verhaert Masters in Innovation is a pioneering innovation group helping companies and entrepreneurs to innovate, creating new products, businesses and services.

Verhaert icon LinkedIn Verhaert icon YouTube Verhaert icon Instagram Verhaert icon phone Verhaert icon mail

Offerings
Markets
Capabilities
Technologies
Perspectives
Blogs
Webinars
About
News
Careers
Contact

© 1969-2026 • Verhaert New Products & Services NV • BE 0439.039.420 • Privacy policy • Terms of use